Generated Narrative: CodeSystem v3-substanceAdminSubstitution Language: en Properties This code system defines the following properties for its concepts Name Code URI Type Description Not Selectable notSelectable http://hl7.org/fhir/concept-properties#notSelectable boolean Indicates that the code is abstract - only intended to be used as a selector for other concepts Status status http://hl7.org/fhir/concept-properties#status code Designation of a concept's state. Normally is not populated unless the state is retired. Concepts This case-sensitive code system http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution defines the following codes in a Is-A hierarchy: Lvl Code Display Definition Not Selectable Status 1 _ActSubstanceAdminSubstitutionCode ActSubstanceAdminSubstitutionCode Substitution occurred or is permitted with another product that may potentially have different ingredients, but having the same biological and therapeutic effects. true active 2 E equivalent Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product. active 3 EC equivalent composition Substitution occurred or is permitted with another product that is a: pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration Examples: Pharmaceutical alternative: Erythromycin Ethylsuccinate for Erythromycin Stearate Pharmaceutical equivalent: Lisonpril for Zestril active 4 BC brand composition Substitution occurred or is permitted between equivalent Brands but not Generics Examples: Zestril for Prinivil Coumadin for Jantoven active 4 G generic composition Substitution occurred or is permitted between equivalent Generics but not Brands Examples: Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp) active 3 TE therapeutic alternative Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile. Examples: ranitidine for Tagamet active 4 TB therapeutic brand Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics Examples: Zantac for Tagamet active 4 TG therapeutic generic Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands Examples: Ranitidine for cimetidine active 2 F formulary This substitution was performed or is permitted based on formulary guidelines. active 2 N none No substitution occurred or is permitted. active
Identifies what sort of change is permitted or has occurred between the therapy that was ordered and the therapy that was/will be provided.
This material derives from the HL7 Terminology THO. THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license.html
Indicates that the code is abstract - only intended to be used as a selector for other concepts
Designation of a concept's state. Normally is not populated unless the state is retired.
Substitution occurred or is permitted with another product that may potentially have different ingredients, but having the same biological and therapeutic effects.
Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product.
Substitution occurred or is permitted with another product that is a: * pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester * pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration *Examples:* * *Pharmaceutical alternative:* Erythromycin Ethylsuccinate for Erythromycin Stearate * *Pharmaceutical equivalent:* Lisonpril for Zestril
Substitution occurred or is permitted between equivalent Brands but not Generics *Examples:* * Zestril for Prinivil * Coumadin for Jantoven
Substitution occurred or is permitted between equivalent Generics but not Brands *Examples:* * Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)
Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile. *Examples:* * ranitidine for Tagamet
Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics > *Examples:* * Zantac for Tagamet
Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands > *Examples:* * Ranitidine for cimetidine
This substitution was performed or is permitted based on formulary guidelines.
No substitution occurred or is permitted.